Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.

Matula S, Croog V, Itzkowitz S, Harpaz N, Bodian C, Hossain S, Ullman T.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):1015-21.

PMID:
16234048
2.

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.

Ullman T, Croog V, Harpaz N, Hossain S, Kornbluth A, Bodian C, Itzkowitz S.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1225-30; quiz 1177. doi: 10.1016/j.cgh.2008.05.020. Epub 2008 Oct 9.

PMID:
18848502
3.

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.

Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S.

Gastroenterology. 2003 Nov;125(5):1311-9.

PMID:
14598247
4.

Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.

Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB.

Clin Gastroenterol Hepatol. 2006 Nov;4(11):1346-50. Epub 2006 Oct 23.

PMID:
17059900
5.

Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?

Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.

Gastrointest Endosc. 2007 Jun;65(7):998-1004. Epub 2007 Apr 23.

PMID:
17451704
6.

Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.

Goldstone R, Itzkowitz S, Harpaz N, Ullman T.

Gastrointest Endosc. 2011 Nov;74(5):1087-93. doi: 10.1016/j.gie.2011.06.028. Epub 2011 Sep 10.

PMID:
21907984
7.

Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.

Kim PS, Zlatanic J, Korelitz BI, Gleim GW.

Am J Gastroenterol. 1999 Nov;94(11):3254-7.

PMID:
10566725
8.

Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

Sjöqvist U, Tribukait B, Ost A, Einarsson C, Oxelmark L, Löfberg R.

Anticancer Res. 2004 Sep-Oct;24(5B):3121-7.

9.

Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.

Gordillo J, Cabré E, Garcia-Planella E, Ricart E, Ber-Nieto Y, Márquez L, Rodríguez-Moranta F, Ponferrada Á, Vera I, Gisbert JP, Barrio J, Esteve M, Merino O, Muñoz F, Domènech E; ENEIDA Project of the Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU).

J Crohns Colitis. 2015 Dec;9(12):1063-70. doi: 10.1093/ecco-jcc/jjv145. Epub 2015 Sep 7.

PMID:
26351379
10.

Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.

Cassinotti A, Actis GC, Duca P, Massari A, Colombo E, Gai E, Annese V, D'Albasio G, Manes G, Travis S, Porro GB, Ardizzone S.

Am J Gastroenterol. 2009 Nov;104(11):2760-7. doi: 10.1038/ajg.2009.410. Epub 2009 Jul 21.

PMID:
19623172
11.
12.

[Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].

Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.

Orv Hetil. 2006 Jan 29;147(4):175-81. Hungarian.

PMID:
16515026
13.

Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis.

Yoshizawa S, Matsuoka K, Inoue N, Takaishi H, Ogata H, Iwao Y, Mukai M, Fujita T, Kawakami Y, Hibi T.

Inflamm Bowel Dis. 2007 Jul;13(7):865-73.

PMID:
17285596
14.

Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.

Goldstone R, Itzkowitz S, Harpaz N, Ullman T.

Inflamm Bowel Dis. 2012 May;18(5):832-7. doi: 10.1002/ibd.21809. Epub 2011 Jul 7.

PMID:
21739534
15.

Will a 5-ASA a day keep the cancer (and dysplasia) away?

Rubin DT, Lashner BA.

Am J Gastroenterol. 2005 Jun;100(6):1354-6.

PMID:
15929769
16.

Intravenous cyclosporin in ulcerative colitis: a five-year experience.

Cohen RD, Stein R, Hanauer SB.

Am J Gastroenterol. 1999 Jun;94(6):1587-92.

PMID:
10364029
17.

Preventing neoplastic progression in ulcerative colitis.

Ullman TA.

J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S66-9. Review.

PMID:
15758662
18.

Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.

Mathy C, Schneider K, Chen YY, Varma M, Terdiman JP, Mahadevan U.

Inflamm Bowel Dis. 2003 Nov;9(6):351-5.

PMID:
14671483
19.

Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.

Kisiel JB, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ.

Inflamm Bowel Dis. 2012 Feb;18(2):226-35. doi: 10.1002/ibd.21687. Epub 2011 Mar 17.

PMID:
21416564
20.

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.

van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.

Gut. 2012 Feb;61(2):235-40. doi: 10.1136/gut.2011.237412. Epub 2011 May 20.

PMID:
21602529

Supplemental Content

Support Center